Skip to main content
. 2012 Aug 8;6:97. doi: 10.1186/1752-0509-6-97

Table 3.

The KEGG pathway enrichment analysis

Pathway description p-value Pathway description p-value
Pathways in cancer
1.10E-42
Fc gamma R-mediated phagocytosis
2.90E-07
Focal adhesion
3.50E-29
RIG-I-like receptor signaling pathway
5.30E-07
Apoptosis
2.10E-17
Chemokine signaling pathway
5.90E-07
Neurotrophin signaling pathway
3.40E-17
Leukocyte transendothelial migration
6.20E-07
TGF-beta signaling pathway
5.10E-16
VEGF signaling pathway
8.60E-07
T cell receptor signaling pathway
8.90E-15
NOD-like receptor signaling pathway
1.20E-06
ErbB signaling pathway
1.80E-14
mTOR signaling pathway
7.00E-06
B cell receptor signaling pathway
8.70E-14
Complement and coagulation cascades
7.90E-06
Adherens junction
2.00E-12
Tight junction
1.10E-05
Fc epsilon RI signaling pathway
3.60E-12
RNA polymerase
1.60E-05
ECM-receptor interaction
6.80E-12
Ubiquitin mediated proteolysis
2.20E-05
Insulin signaling pathway
3.00E-10
GnRH signaling pathway
1.10E-04
Regulation of actin cytoskeleton
3.10E-09
Hematopoietic cell lineage
1.20E-04
Toll-like receptor signaling pathway
1.01E-08
Cytokine-cytokine receptor interaction
2.00E-04
Wnt signaling pathway
1.10E-08
Hedgehog signaling pathway
3.70E-04
Cell cycle
1.50E-08
Natural killer cell mediated cytotoxicity
3.80E-04
MAPK signaling pathway
1.50E-08
Cytosolic DNA-sensing pathway
6.70E-04
Adipocytokine signaling pathway
7.50E-08
Notch signaling pathway
2.60E-03
Progesterone-mediated oocyte maturation 2.50E-07 Renin-angiotensin system 1.80E-02

The table provides the p-value obtained from pathway enrichment analysis in the KEGG database. The pathways names correspond with the KEGG nomenclature. The results showed are partials as discussed in the respective section.